Skip to main content

Table 1 Overview of the lab parameters

From: Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report

Date

CRP

(< 5 mg/L)

Troponin T-hs

(< 14 ng/L)

NT-pro BNP

(< 125 pg/mL)

CK

(< 190 U/L)

CK-MB

(< 6.6 ng/mL)

13/11/2020

4.51

    

02/12/2020

39.72

12.75

214.3

95

 

23/12/2020

46.49

43.02

308.1

103

1.2

30/12/2020

40.48

35.58

189.0

83

1.2

06/01/2021

33.10

35.21

270.4

81

 

13/01/2021

12.28

93.11

457.1

57

 

15/01/2021

11.50

147.50

464.7

67

 

18/01/2021

6.94

107.30

 

33

 

20/01/2021

10.00

176.00

 

61

 

27/01/2021

9.86

135.10

   

28/01/2021

9.76

101.80

   

29/01/2021

7.86

99.49

   

30/01/2021

6.42

92.40

   

03/02/2021

8.52

52.19

 

55

 

10/02/2021

16.60

57.07

 

54

 

17/02/2021

12.93

43.18

   
  1. CRP C-reactive protein; Troponin T-hs troponin T-high sensitive; NT-pro BNP N-terminal pro-B-type natriuretic peptide; CK creatine kinase; CK-MB creatine kinase–myocardial band